Theta Therapeutics, Inc
Biotechnology Research • 
Bunkyo-Ku, Tokyo, Japan • 1-10 Employees
Key Contact at Theta Therapeutics, Inc
Yoshihiro Tachihara
CEO
About Theta Therapeutics, Inc
Theta Therapeutics is a biotech startup originating from university research. We specialize in formulation development for macrocyclic drug candidates aimed at treating rare and intractable diseases. Macrocyclic compounds represent a new class of therapeutics with unique cyclic structures, different from small molecules, nucleic acids, or antibodies. Although they hold great potential in areas such as oncology, their development is often hindered by issues like low solubility, toxicity, and inefficient delivery. Our mission is to address these barriers by creating innovative formulations that preserve therapeutic activity while enhancing solubility, safety, and tolerability.
Theta Therapeutics, Inc revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Theta Therapeutics, Inc has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Theta Therapeutics, Inc has never raised funding before.
United States
Frequently asked questions
4.8
40,000 users
